Featured
User Account Blocked by Social Media Platform
Breath Work Aug 6, 2026
Gut Checks Aug 6, 2026
Rest Logs Aug 5, 2026
The FDA will review tau PET imaging agent MK-6240 on August 13, seeking better Alzheimer...
Burnout in nurses increases missed care risks, especially in neuro-oncology, with resilience and professional identity...
Learn about multiple sclerosis treatment and factors influencing discontinuation of disease-modifying therapy for ms patients...
Read our latest Gut Checks articles.
New data regarding CIDP treatment with efgartigimod PH20 reveals long-term patient outcomes for clinicians based...
Discover latest multiple sclerosis research and clinical trials at the forefront of medical science for...
Criminal responsibility age reforms spark debate in Australia as medical groups push to raise the...
The FDA will review tau PET imaging agent MK-6240 on August 13, seeking better Alzheimer disease diagnosis by detecting tau tangles with high specificity and...
The FDA will review tau PET imaging agent MK-6240 on August 13, seeking better Alzheimer disease diagnosis by detecting tau...
New data regarding CIDP treatment with efgartigimod PH20 reveals long-term patient outcomes for clinicians based on recent clinical study data.
Aspen Neuroscience's sasineprocel receives FDA RMAT designation for Parkinson disease, accelerating development and potentially enabling accelerated approval.
High-dose NAC treatment shows promise in reducing brain damage markers in progressive MS patients, according to a new clinical trial.
New tools and strategies are transforming alzheimer diagnosis despite cost barriers. Learn about the latest research and clinical access.
New Alzheimer’s blood test shows high reliability matching PET scans, advancing early detection for cognitive decline.
Discover how minimally invasive spine treatment combines advanced techniques and pain specialists for better outcomes without surgery.
Burnout in nurses increases missed care risks, especially in neuro-oncology, with resilience and professional identity as key factors.
Learn about multiple sclerosis treatment and factors influencing discontinuation of disease-modifying therapy for ms patients effectively.
An experimental Alzheimer's drug shows promising results in a clinical trial by reducing brain damage biomarkers with a strong safety...